Southland Equity Partners LLC Novo Nordisk A S Transaction History
Southland Equity Partners LLC
- $411 Billion
- Q3 2024
A detailed history of Southland Equity Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Southland Equity Partners LLC holds 5,578 shares of NVO stock, worth $608,504. This represents 0.16% of its overall portfolio holdings.
Number of Shares
5,578
Previous 5,541
0.67%
Holding current value
$608,504
Previous $791 Million
16.04%
% of portfolio
0.16%
Previous 0.23%
Shares
14 transactions
Others Institutions Holding NVO
# of Institutions
1,950Shares Held
319MCall Options Held
5.22MPut Options Held
5M-
Jennison Associates LLC20.2MShares$2.2 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.59 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.55 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.46 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.37 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $246B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...